Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study

BACKGROUND: Plerixafor was approved in Japan in 2016 for peripheral blood stem cell (PBSC) mobilization in autologous stem cell transplantation (A-SCT). OBJECTIVE: Our objective was to evaluate the safety and effectiveness of plerixafor in Japanese patients undergoing A-SCT for various indications i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukada, Nobuhiro, Nishikori, Momoko, Goto, Hiroaki, Kanamori, Rie, Nishina, Satoshi, Seto, Takashi, Iida, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844333/
https://www.ncbi.nlm.nih.gov/pubmed/34455570
http://dx.doi.org/10.1007/s40801-021-00276-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844333/
https://www.ncbi.nlm.nih.gov/pubmed/34455570
http://dx.doi.org/10.1007/s40801-021-00276-1

Ejemplares similares